Amy Marsden: Vipoglanstat – A New Treatment for Endometriosis
Amy Marsden, Exam Support Worker at The University of Sheffield, shared a post on LinkedIn:
“Gesynta is developing a new treatment for endometriosis called Vipoglanstat, currently in Phase II of clinical trials. I am really happy to be finding out about this and I wanted to share how it links to my final year research project.
Endometriosis, a gynaecological condition which impacts 1 in 10 menstruators, is currently treated through hormonal-based treatments, painkillers and surgery. These options alleviate symptoms and don’t provide enough relief to most patients.
Last year, I focused my research on a policy proposal (abstract attached) aimed at accelerating the diagnosis of endometriosis through non-invasive tools. By prioritising funding, this approach could help patients access support sooner. However, I was mindful that even with an earlier diagnosis, there lacks an effective drug capable of treating the condition.
This might not be the case for much longer, though. Gesynta has been working on a specific drug that targets Microsomal prostaglandin E synthase (mPGES-1), an enzyme present at high levels in inflamed tissues found in endometriosis lesions. Through the inhibition of mPGES-1, downstream inflammation is reduced.
I am excited to see this work develop.
Link to more information.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 1, 2026, 03:13International Expert Recommendations in Emerging Reproductive Science – ESHRE
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE